setrobuvir

DRUG3 trials

Sponsors

Hoffmann-La Roche

Conditions

Healthy VolunteerHepatitis C, Chronic

Phase 1

A Relative Bioavailability Study of Setrobuvir Tablet Formulation Versus Reference Setrobuvir Capsule Formulation in Healthy Volunteers

CompletedNCT01612143

Hoffmann-La RocheHealthy Volunteer

Start: 2012-06-30End: 2012-09-30Updated: 2016-11-02

A Safety And Pharmacokinetic Study of Setrobuvir Alone and In Combination With Ritonavir-Boosted Danoprevir in Subjects With Mild Hepatic Impairment Compared to Healthy Controls

CompletedNCT01714154

Hoffmann-La RocheHealthy Volunteer

Start: 2012-11-30End: 2013-05-31Updated: 2016-11-02

Phase 2

A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C

CompletedNCT01903954

Hoffmann-La RocheHepatitis C, Chronic

Start: 2011-01-31End: 2013-05-31Updated: 2016-11-02